COVID-19 May Cause Severe Illness in Diabetic Patients
Main Article Content
Abstract
COVID-19 pandemic has become the top public health concern worldwide that represents a threat to the life of billions of people globally. Common causes of death of COVID-19 infected individuals are multi-organ failure, pneumonia, and acute respiratory distress syndrome, out of which pneumonia is the most common. COVID-19 patients with diabetes are at high risk for medical complications, which may lead to severe complications, even death.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submission of any work for publication in this journal would imply that the authors acknowledge that the work is their own and that they have taken all necessary permissions for all the materials used in their work.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors permit us for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
References
Ahirwar AK, Asia P, Sakarde A, Kaim K (2020). “COVID-19 outbreak–
Diabetes aspect and perspective.†Current Medicine Research and Practice. doi:https://doi.org/10.1016/j.cmrp.2020.05.005.
Hill MA, Mantzoros C, Sowers JR (2020). “Commentary: COVID-19 in patients with diabetes.â€Metabolism. doi:https://doi.org/10.1016/j.metabol.2020.154217.
Hossain MS, Ferdous S, Siddiqee MH (2020). “Mass panic during Covid-19 outbreak–A perspective from Bangladesh as a high-risk country.†Journal of Biomedical Analytics, 3(2),1–3. doi:https://doi.org/10.30577/jba.v3i2.40.
IEDCR (accessed June 1, 2020). “Institute of Epidemiology Disease Control and Research.†URL https://www.iedcr.gov.bd/.
Klonoff DC, Umpierrez GE (2020). “COVID-19 in patients with diabetes:risk factors that increase morbidity.†Metabolism-Clinical and Experimental. doi:https://doi.org/10.1016/j.metabol.2020.154224.
Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A (2020). “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.†Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
doi:https://doi.org/10.1016/j.dsx.2020.04.044.
Kwong KCNK, Mehta PR, Shukla G, Mehta AR (2020). “COVID-19, SARS and MERS: A neurological perspective.†Journal of Clinical Neuroscience. doi:https://doi.org/10.1016/j.jocn.2020.04.124.
Miazgowski T, Bikowska M, Ogonowski J, Taszarek A (2018). “The Impact of Health Locus of Control and Anxiety on Self-Monitored Blood Glucose Concentration in Women with Gestational Diabetes Mellitus.†Journal of Women’s Health, 27(2), 209–215. doi:https://doi.org/10.1089/jwh.2017.6366.
WHO (accessed June 1, 2020). “WHO Coronavirus Disease (COVID-19) Dashboard n.d.†URL https://bit.ly/2XFrMH9.
WHO (accessed May 24, 2020). “WHO Director-General’s remarks at the media briefingon 2019-nCoV on 11 February 2020.†URL https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
Zhou J, Tan J (2020). “Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.†Metabolism-Clinical and Experimental, 107. doi:https://doi.org/10.1016/j.metabol.2020.154216.